Home / Research / Manufacturers / Thermo Fisher Scientific Medical-device intelligence
Thermo Fisher Scientific: FDA clearances and recalls Research Thermo Fisher Scientific in public FDA records: applicant and recalling-firm names, product codes, clearance history, and recall records.
Names and coverage This profile groups matching applicant and recalling-firm names found in covered FDA records. It does not imply a complete corporate family, current ownership, or every product marketed under a brand.
Names observed in the source
Capitalization and punctuation variants are normalized. Customer-entered watchlist aliases remain private.
Product codes in this company’s records Record activity in this scope 64 clearance records and 5 recall records in the covered releases, across 1 source company names and 16 product codes. Dated history runs from May 22, 2007 to Sep 25, 2025.
Monthly counts through October 2026 Month 510(k) decisions Recall initiations October 2025 0 0 November 2025 0 0 December 2025 0 0 January 2026 0 0 February 2026 0 0 March 2026 0 0 April 2026 0 0 May 2026 0 0 June 2026 0 0 July 2026 0 0 August 2026 0 0 September 2026 0 0 October 2026 0 0
Product codes represented Code and FDA device name Clearances Recalls JWY · Manual Antimicrobial Susceptibility Test Systems 47 0 NGZ · Susceptibility Test Plate, Antifungal 5 0 IDP · Microtome, Cryostat 0 2 JSO · Culture Media, Antimicrobial Susceptibility Test, Excluding Mueller Hinton Agar 2 0 LRG · Instrument For Auto Reader & Interpretation Of Overnight Suscept. Systems 2 0 CGZ · Electrode, Ion-Specific, Chloride 1 0 DHB · System, Test, Radioallergosorbent (Rast) Immunological 1 0 DIF · Drug Mixture Control Materials 1 0 DJR · Enzyme Immunoassay, Methadone 1 0 DLJ · Calibrators, Drug Specific 1 0 DOP · Mass Spectrometer, Clinical Use 0 1 IEO · Processor, Tissue, Automated 0 1
All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.
Clearances and recall records 69 matching records Device / record Company in FDA record Source Source date Sensititre YeastOne Susceptibility System with Voriconazole in the dilution range of 0.008 - 8 ug/mL K211539 · NGZThermo Fisher Scientific 510(k) Dec 15, 2021FDA decision date Sensititre 20-24 hour Haemophilus influenzae /Streptococcus pneumoniae MIC or Breakpoint Susceptibility System with Dtest (containing erythromyci… K202612 · JWYThermo Fisher Scientific 510(k) Jul 23, 2021FDA decision date Cascadion SM Clinical Analyzer, REF 99990000 SN Type: 9910 Z-1202-2021 · DOPThermo Fisher Scientific Recall Mar 10, 2021FDA record creation date Sensititre 18-24 hour MIC or Breakpoint Susceptibility System with Cefiderocol in the dilution range of 0.03-64 µg/ml K193538 · JWYThermo Fisher Scientific 510(k) Mar 12, 2020FDA decision date Sensititre 20-24 hour Haemophilus influenzae/Streptococcus pneumoniae MIC or Breakpoint, Susceptibility System with Lefamulin in the dilution ran… K193024 · JWYThermo Fisher Scientific 510(k) Jan 8, 2020FDA decision date Thermo Scientific Sensititre ARIS HiQ System K191914 · LRGThermo Fisher Scientific 510(k) Nov 6, 2019FDA decision date Thermo Scientific Sensititre ARIS HiQ System K191918 · LRGThermo Fisher Scientific 510(k) Nov 6, 2019FDA decision date Sensititre 18-24 Hour MIC or Breakpoint Susceptibility System with Lefamulin in the dilution range of 0.008-16ug/ml K192729 · JWYThermo Fisher Scientific 510(k) Nov 6, 2019FDA decision date Sensititre 18-24 hour MIC or Breakpoint Susceptibility System with Imipenem-Relebactam in the dilution range of 0.03/4-256/4 ug/mL K192250 · JWYThermo Fisher Scientific 510(k) Oct 16, 2019FDA decision date Sensititre 20-24 hour Haemophilus influenzae/Streptococcus pneumoniae MIC or Breakpoint Susceptibility System with Omadacycline in the dilution r… K183324 · JWYThermo Fisher Scientific 510(k) Feb 15, 2019FDA decision date Sensititre 18-24 hour MIC or Breakpoint Susceptibility System with Omadacycline in the dilution range of 0.03-32ug/ml K183033 · JWYThermo Fisher Scientific 510(k) Jan 4, 2019FDA decision date Sensititre 18-24 hour MIC or Breakpoint Susceptibility System with Eravacycline in the dilution range of 0.008- 16 µg/mL K182797 · JWYThermo Fisher Scientific 510(k) Nov 30, 2018FDA decision date Sensititre 18-24 hour MIC Breakpoint Susceptibility System with Plazomicin in the dilution range of 0.06-128 ug/mL K181946 · JWYThermo Fisher Scientific 510(k) Aug 8, 2018FDA decision date Sensititre 18-24 hour MIC or Breakpoint Susceptibility System with Meropenem/Vaborbactam in the Dilution Range of 0.008/8 - 18/8 ug/mL K173209 · JWYThermo Fisher Scientific 510(k) Dec 1, 2017FDA decision date Sensititre 18-24 hour MIC or Breakpoint Susceptibility System with Delafloxacin in the dilution range of 0.004-8 ug/mL K172454 · JWYThermo Fisher Scientific 510(k) Oct 13, 2017FDA decision date The Sensititre 20-24 hour Haemophilus influenzae/Streptococcus pneumoniae MIC or Breakpoint Susceptibility System with Delafloxacin in the diluti… K172274 · JWYThermo Fisher Scientific 510(k) Aug 30, 2017FDA decision date The Sensititre 18-24 hour MIC or Breakpoint Susceptibility System with Delafloxacin in the dilution range of 0.0005 8 ug/mL K171870 · JWYThermo Fisher Scientific 510(k) Aug 1, 2017FDA decision date The Sensititre 18-24 hour MIC or Breakpoint Susceptibility System with Ceftazidime/Avibactam in the dilutions range of 0.015/4 - 32/4 ug/mL K152774 · JWYThermo Fisher Scientific 510(k) Dec 21, 2015FDA decision date Sensititre 18-24 hours MIC or BP Susceptibility System with Ceftolozane/tazobactam (0.03/4- 64/4ug/mL) K150556 · JWYThermo Fisher Scientific 510(k) Aug 28, 2015FDA decision date Sensititre 18 - 24 hour MIC or Breakpoint Susceptibility System with Dalbavancin (0.0005 - 2ug/mL) K150236 · JWYThermo Fisher Scientific 510(k) Jul 27, 2015FDA decision date Sensititre Susceptibility plates K143288 · JWYThermo Fisher Scientific 510(k) Apr 1, 2015FDA decision date The Sensititre HP MIC Susceptibility plate with Oritavancin (0.0005-8mcg/ml) K143526 · JWYThermo Fisher Scientific 510(k) Mar 5, 2015FDA decision date Sensititre HP MIC Susceptibility Plate with Tedizolid (0.002-4 mcg/ml) K142338 · JWYThermo Fisher Scientific 510(k) Mar 2, 2015FDA decision date Sensititre Susceptibility Plates K143381 · JWYThermo Fisher Scientific 510(k) Feb 19, 2015FDA decision date SENSITITRE 18-24 HOUR SUSCEPTIBILITY PLATES K142151 · JWYThermo Fisher Scientific 510(k) Dec 23, 2014FDA decision date
Device classifications FDA dataset: Nov 9, 2026
Last successful check: Nov 22, 2026
Source classifications may change.
510(k) clearances FDA dataset: Nov 9, 2026
Last successful check: Nov 22, 2026
FDA publishes this dataset monthly.
Recall records FDA dataset: Nov 19, 2026
Last successful check: Nov 22, 2026
FDA publishes this dataset weekly.
Keep this research moving. Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.
Start a 14-day free trial ↗